As part of National Pet Cancer Awareness Month in November, Nationwide is engaging claims data to offer unique analyses and pledging support for pet cancer research.
A cancer diagnosis is heartbreaking for any pet owner. Continued research and investment are needed to push for advancement in the early detection, treatment options, and technology that can make a difference.
In support of National Pet Cancer Awareness Month, Nationwide is sharing its insights into the disease that affects so many pets. Nationwide recently released a report that analyzed claims data representing more than 1.5 million dogs over a six-year period, and it is sharing those findings with the rest of the industry. According to Nationwide Chief Veterinary Officer Dr Jules Benson, Nationwide members submitted claims for nearly $50 million in 2020 for the diagnosis and treatment of cancer in their pets.
Benson stated, “As pet lovers ourselves, we know the emotional impact behind these numbers, and that’s why we’re expanding our efforts in leveraging our industry-leading claims data to provide vital information to pet parents and veterinary teams alike.” Here are some of the key takeaways from the report:1
Nationwide stressed that research and data play vital roles in the early detection aspect of cancer. “The signs of cancer in pets can be vague, and can also be shared by other diseases,” said Benson. “but having more information about cancer prevalence rates and what types of cancer are likely to occur can be key to an early diagnosis, and that can mean access to more treatment options and better outcomes.”
Benson advises that veterinarians should pay particular attention to weight loss, major changes in appetite or thirst, and changes in energy level of their patients.
Anyone who registers with the WoofTrax mobile app can help contribute to the fight against cancer. When registered participants track their walks between now and November 30, 2021, Nationwide will donate 50 cents per walk (up to $60,000) to the Animal Cancer Foundation.
Reference
Nationwide dedicates research, funding in fight to #CurePetCancer. November 4, 2021; Nationwide Mutual Insurance Company. Accessed November 10, 2021. https://news.nationwide.com/nationwide-dedicates-research-to-curepetcancer/
Presurgical evaluation and diagnostic imaging for canine mast cell tumors
November 7th 2024Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York
Read More